nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.175	0.263	CbGbCtD
Cevimeline—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.152	0.229	CbGbCtD
Cevimeline—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0575	0.0864	CbGbCtD
Cevimeline—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0575	0.0864	CbGbCtD
Cevimeline—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0512	0.077	CbGbCtD
Cevimeline—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0482	0.0725	CbGbCtD
Cevimeline—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0326	0.049	CbGbCtD
Cevimeline—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0311	0.0467	CbGbCtD
Cevimeline—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0277	0.0417	CbGbCtD
Cevimeline—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0163	0.0244	CbGbCtD
Cevimeline—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0154	0.0231	CbGbCtD
Cevimeline—FMO1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00061	0.013	CbGpPWpGaD
Cevimeline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000597	0.0127	CbGpPWpGaD
Cevimeline—CHRM3—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000521	0.0111	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000515	0.011	CbGpPWpGaD
Cevimeline—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000514	0.011	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000508	0.0108	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000501	0.0107	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.0005	0.0106	CbGpPWpGaD
Cevimeline—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000494	0.0105	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000474	0.0101	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000467	0.00995	CbGpPWpGaD
Cevimeline—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000463	0.00985	CbGpPWpGaD
Cevimeline—FMO1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000449	0.00957	CbGpPWpGaD
Cevimeline—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000447	0.00951	CbGpPWpGaD
Cevimeline—FMO1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000443	0.00943	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000421	0.00898	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00042	0.00895	CbGpPWpGaD
Cevimeline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000402	0.00856	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000392	0.00835	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000391	0.00832	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000382	0.00814	CbGpPWpGaD
Cevimeline—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000374	0.00796	CbGpPWpGaD
Cevimeline—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.00779	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000361	0.0077	CbGpPWpGaD
Cevimeline—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000359	0.00765	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000354	0.00754	CbGpPWpGaD
Cevimeline—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00035	0.00746	CbGpPWpGaD
Cevimeline—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000336	0.00716	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000329	0.00702	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000328	0.007	CbGpPWpGaD
Cevimeline—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00689	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000296	0.00631	CbGpPWpGaD
Cevimeline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000292	0.00622	CbGpPWpGaD
Cevimeline—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00028	0.00597	CbGpPWpGaD
Cevimeline—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00591	CbGpPWpGaD
Cevimeline—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00566	CbGpPWpGaD
Cevimeline—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.0052	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000239	0.0051	CbGpPWpGaD
Cevimeline—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.005	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GC—chronic obstructive pulmonary disease	0.000233	0.00496	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000222	0.00473	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00468	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000218	0.00465	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000216	0.00461	CbGpPWpGaD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00455	CbGpPWpGaD
Cevimeline—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.00449	CbGpPWpGaD
Cevimeline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.000667	CcSEcCtD
Cevimeline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000665	CcSEcCtD
Cevimeline—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000191	0.000665	CcSEcCtD
Cevimeline—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.000665	CcSEcCtD
Cevimeline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.000664	CcSEcCtD
Cevimeline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000664	CcSEcCtD
Cevimeline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00019	0.000661	CcSEcCtD
Cevimeline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.000661	CcSEcCtD
Cevimeline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00066	CcSEcCtD
Cevimeline—Infection—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00066	CcSEcCtD
Cevimeline—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000659	CcSEcCtD
Cevimeline—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00019	0.000658	CcSEcCtD
Cevimeline—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.000658	CcSEcCtD
Cevimeline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.000656	CcSEcCtD
Cevimeline—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000652	CcSEcCtD
Cevimeline—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000187	0.000651	CcSEcCtD
Cevimeline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00065	CcSEcCtD
Cevimeline—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00065	CcSEcCtD
Cevimeline—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000649	CcSEcCtD
Cevimeline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000186	0.000645	CcSEcCtD
Cevimeline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00064	CcSEcCtD
Cevimeline—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000636	CcSEcCtD
Cevimeline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000633	CcSEcCtD
Cevimeline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000633	CcSEcCtD
Cevimeline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00063	CcSEcCtD
Cevimeline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00063	CcSEcCtD
Cevimeline—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000629	CcSEcCtD
Cevimeline—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000628	CcSEcCtD
Cevimeline—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000627	CcSEcCtD
Cevimeline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000625	CcSEcCtD
Cevimeline—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000624	CcSEcCtD
Cevimeline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000622	CcSEcCtD
Cevimeline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.000619	CcSEcCtD
Cevimeline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.000619	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000618	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000618	CcSEcCtD
Cevimeline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000613	CcSEcCtD
Cevimeline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000613	CcSEcCtD
Cevimeline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00061	CcSEcCtD
Cevimeline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.000609	CcSEcCtD
Cevimeline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000607	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000605	CcSEcCtD
Cevimeline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.000604	CcSEcCtD
Cevimeline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.000604	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000174	0.0037	CbGpPWpGaD
Cevimeline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000603	CcSEcCtD
Cevimeline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000603	CcSEcCtD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00369	CbGpPWpGaD
Cevimeline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.0006	CcSEcCtD
Cevimeline—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00368	CbGpPWpGaD
Cevimeline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000598	CcSEcCtD
Cevimeline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000172	0.000597	CcSEcCtD
Cevimeline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.000597	CcSEcCtD
Cevimeline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.000596	CcSEcCtD
Cevimeline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.000594	CcSEcCtD
Cevimeline—Injury—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00059	CcSEcCtD
Cevimeline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00059	CcSEcCtD
Cevimeline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.000589	CcSEcCtD
Cevimeline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000587	CcSEcCtD
Cevimeline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000584	CcSEcCtD
Cevimeline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000584	CcSEcCtD
Cevimeline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000584	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000583	CcSEcCtD
Cevimeline—Pain—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00058	CcSEcCtD
Cevimeline—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00058	CcSEcCtD
Cevimeline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00058	CcSEcCtD
Cevimeline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00058	CcSEcCtD
Cevimeline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000579	CcSEcCtD
Cevimeline—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000578	CcSEcCtD
Cevimeline—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000578	CcSEcCtD
Cevimeline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.000575	CcSEcCtD
Cevimeline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000572	CcSEcCtD
Cevimeline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000571	CcSEcCtD
Cevimeline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000569	CcSEcCtD
Cevimeline—Pain—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000568	CcSEcCtD
Cevimeline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000567	CcSEcCtD
Cevimeline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.000566	CcSEcCtD
Cevimeline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000564	CcSEcCtD
Cevimeline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000564	CcSEcCtD
Cevimeline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000563	CcSEcCtD
Cevimeline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000563	CcSEcCtD
Cevimeline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.000562	CcSEcCtD
Cevimeline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.000561	CcSEcCtD
Cevimeline—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000559	CcSEcCtD
Cevimeline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000559	CcSEcCtD
Cevimeline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000559	CcSEcCtD
Cevimeline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.000558	CcSEcCtD
Cevimeline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000556	CcSEcCtD
Cevimeline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.000555	CcSEcCtD
Cevimeline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000554	CcSEcCtD
Cevimeline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000554	CcSEcCtD
Cevimeline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000552	CcSEcCtD
Cevimeline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000547	CcSEcCtD
Cevimeline—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000547	CcSEcCtD
Cevimeline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000543	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000543	CcSEcCtD
Cevimeline—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000543	CcSEcCtD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.0033	CbGpPWpGaD
Cevimeline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000538	CcSEcCtD
Cevimeline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000538	CcSEcCtD
Cevimeline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000536	CcSEcCtD
Cevimeline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000536	CcSEcCtD
Cevimeline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000536	CcSEcCtD
Cevimeline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000536	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000154	0.00329	CbGpPWpGaD
Cevimeline—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000534	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000154	0.00328	CbGpPWpGaD
Cevimeline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.000534	CcSEcCtD
Cevimeline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00326	CbGpPWpGaD
Cevimeline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00053	CcSEcCtD
Cevimeline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.000529	CcSEcCtD
Cevimeline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.000529	CcSEcCtD
Cevimeline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000527	CcSEcCtD
Cevimeline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000527	CcSEcCtD
Cevimeline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.000526	CcSEcCtD
Cevimeline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000525	CcSEcCtD
Cevimeline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000525	CcSEcCtD
Cevimeline—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000524	CcSEcCtD
Cevimeline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000523	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000151	0.00321	CbGpPWpGaD
Cevimeline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00015	0.0032	CbGpPWpGaD
Cevimeline—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00015	0.00319	CbGpPWpGaD
Cevimeline—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000519	CcSEcCtD
Cevimeline—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000517	CcSEcCtD
Cevimeline—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000514	CcSEcCtD
Cevimeline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000508	CcSEcCtD
Cevimeline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000506	CcSEcCtD
Cevimeline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000506	CcSEcCtD
Cevimeline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000499	CcSEcCtD
Cevimeline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000499	CcSEcCtD
Cevimeline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.000499	CcSEcCtD
Cevimeline—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000498	CcSEcCtD
Cevimeline—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000497	CcSEcCtD
Cevimeline—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000143	0.00304	CbGpPWpGaD
Cevimeline—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000494	CcSEcCtD
Cevimeline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000489	CcSEcCtD
Cevimeline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000486	CcSEcCtD
Cevimeline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000486	CcSEcCtD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00297	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000138	0.00294	CbGpPWpGaD
Cevimeline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00048	CcSEcCtD
Cevimeline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00048	CcSEcCtD
Cevimeline—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000479	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000479	CcSEcCtD
Cevimeline—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00293	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000138	0.00293	CbGpPWpGaD
Cevimeline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000476	CcSEcCtD
Cevimeline—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000472	CcSEcCtD
Cevimeline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000472	CcSEcCtD
Cevimeline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00047	CcSEcCtD
Cevimeline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000464	CcSEcCtD
Cevimeline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000464	CcSEcCtD
Cevimeline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000462	CcSEcCtD
Cevimeline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000459	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000132	0.00281	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000132	0.00281	CbGpPWpGaD
Cevimeline—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000457	CcSEcCtD
Cevimeline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000454	CcSEcCtD
Cevimeline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000453	CcSEcCtD
Cevimeline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000448	CcSEcCtD
Cevimeline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000448	CcSEcCtD
Cevimeline—FMO1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000127	0.00271	CbGpPWpGaD
Cevimeline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000439	CcSEcCtD
Cevimeline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000438	CcSEcCtD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00268	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000126	0.00268	CbGpPWpGaD
Cevimeline—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00267	CbGpPWpGaD
Cevimeline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000432	CcSEcCtD
Cevimeline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000431	CcSEcCtD
Cevimeline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000431	CcSEcCtD
Cevimeline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000427	CcSEcCtD
Cevimeline—Rash—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000427	CcSEcCtD
Cevimeline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000427	CcSEcCtD
Cevimeline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000427	CcSEcCtD
Cevimeline—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000427	CcSEcCtD
Cevimeline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000425	CcSEcCtD
Cevimeline—Headache—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000425	CcSEcCtD
Cevimeline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000424	CcSEcCtD
Cevimeline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000423	CcSEcCtD
Cevimeline—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000423	CcSEcCtD
Cevimeline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000422	CcSEcCtD
Cevimeline—Rash—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000419	CcSEcCtD
Cevimeline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000418	CcSEcCtD
Cevimeline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000417	CcSEcCtD
Cevimeline—Depression—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000417	CcSEcCtD
Cevimeline—Headache—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000416	CcSEcCtD
Cevimeline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000412	CcSEcCtD
Cevimeline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00041	CcSEcCtD
Cevimeline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00041	CcSEcCtD
Cevimeline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000407	CcSEcCtD
Cevimeline—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000406	CcSEcCtD
Cevimeline—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000404	CcSEcCtD
Cevimeline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000404	CcSEcCtD
Cevimeline—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000403	CcSEcCtD
Cevimeline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000403	CcSEcCtD
Cevimeline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000403	CcSEcCtD
Cevimeline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000403	CcSEcCtD
Cevimeline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000401	CcSEcCtD
Cevimeline—FMO1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000115	0.00244	CbGpPWpGaD
Cevimeline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000395	CcSEcCtD
Cevimeline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000394	CcSEcCtD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00241	CbGpPWpGaD
Cevimeline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00039	CcSEcCtD
Cevimeline—CHRM1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000112	0.00238	CbGpPWpGaD
Cevimeline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000388	CcSEcCtD
Cevimeline—CHRM3—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000111	0.00238	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00236	CbGpPWpGaD
Cevimeline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00038	CcSEcCtD
Cevimeline—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000109	0.00233	CbGpPWpGaD
Cevimeline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000378	CcSEcCtD
Cevimeline—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000377	CcSEcCtD
Cevimeline—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000375	CcSEcCtD
Cevimeline—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000374	CcSEcCtD
Cevimeline—FMO1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.00225	CbGpPWpGaD
Cevimeline—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000367	CcSEcCtD
Cevimeline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000361	CcSEcCtD
Cevimeline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000358	CcSEcCtD
Cevimeline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000355	CcSEcCtD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00216	CbGpPWpGaD
Cevimeline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000351	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000101	0.00214	CbGpPWpGaD
Cevimeline—Flushing—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000348	CcSEcCtD
Cevimeline—CHRM3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0001	0.00214	CbGpPWpGaD
Cevimeline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00213	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.0001	0.00213	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	9.97e-05	0.00212	CbGpPWpGaD
Cevimeline—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000341	CcSEcCtD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	9.78e-05	0.00208	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	9.75e-05	0.00208	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	9.67e-05	0.00206	CbGpPWpGaD
Cevimeline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000335	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	9.64e-05	0.00205	CbGpPWpGaD
Cevimeline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.000332	CcSEcCtD
Cevimeline—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.000332	CcSEcCtD
Cevimeline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.49e-05	0.00033	CcSEcCtD
Cevimeline—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.41e-05	0.000327	CcSEcCtD
Cevimeline—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.19e-05	0.00196	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.07e-05	0.00193	CbGpPWpGaD
Cevimeline—Pain—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.000314	CcSEcCtD
Cevimeline—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	8.99e-05	0.00191	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.81e-05	0.00188	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	8.75e-05	0.00186	CbGpPWpGaD
Cevimeline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.000303	CcSEcCtD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	8.72e-05	0.00186	CbGpPWpGaD
Cevimeline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000302	CcSEcCtD
Cevimeline—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000302	CcSEcCtD
Cevimeline—FMO1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.69e-05	0.00185	CbGpPWpGaD
Cevimeline—Agitation—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.0003	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.59e-05	0.00183	CbGpPWpGaD
Cevimeline—Malaise—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000295	CcSEcCtD
Cevimeline—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.45e-05	0.000294	CcSEcCtD
Cevimeline—Syncope—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000293	CcSEcCtD
Cevimeline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.4e-05	0.000292	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.29e-05	0.00177	CbGpPWpGaD
Cevimeline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000287	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.26e-05	0.00176	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.24e-05	0.00176	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.22e-05	0.00175	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.22e-05	0.00175	CbGpPWpGaD
Cevimeline—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000283	CcSEcCtD
Cevimeline—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000282	CcSEcCtD
Cevimeline—FMO1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.1e-05	0.00173	CbGpPWpGaD
Cevimeline—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000278	CcSEcCtD
Cevimeline—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000278	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	8e-05	0.0017	CbGpPWpGaD
Cevimeline—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000277	CcSEcCtD
Cevimeline—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.000275	CcSEcCtD
Cevimeline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.79e-05	0.00027	CcSEcCtD
Cevimeline—Oedema—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000267	CcSEcCtD
Cevimeline—FMO1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.68e-05	0.00164	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.67e-05	0.00163	CbGpPWpGaD
Cevimeline—Infection—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.000265	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.56e-05	0.00161	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.56e-05	0.00161	CbGpPWpGaD
Cevimeline—Shock—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.000262	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.54e-05	0.00161	CbGpPWpGaD
Cevimeline—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.53e-05	0.000262	CcSEcCtD
Cevimeline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.00026	CcSEcCtD
Cevimeline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000259	CcSEcCtD
Cevimeline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000258	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.41e-05	0.00158	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.38e-05	0.00157	CbGpPWpGaD
Cevimeline—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000254	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.23e-05	0.00154	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.15e-05	0.00152	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.05e-05	0.0015	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.05e-05	0.0015	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.03e-05	0.0015	CbGpPWpGaD
Cevimeline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000243	CcSEcCtD
Cevimeline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.99e-05	0.000243	CcSEcCtD
Cevimeline—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.95e-05	0.00148	CbGpPWpGaD
Cevimeline—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000241	CcSEcCtD
Cevimeline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.00024	CcSEcCtD
Cevimeline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000235	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.74e-05	0.00144	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.68e-05	0.00142	CbGpPWpGaD
Cevimeline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000232	CcSEcCtD
Cevimeline—Rash—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000231	CcSEcCtD
Cevimeline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000231	CcSEcCtD
Cevimeline—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.00023	CcSEcCtD
Cevimeline—Headache—Prednisolone—chronic obstructive pulmonary disease	6.62e-05	0.00023	CcSEcCtD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.59e-05	0.0014	CbGpPWpGaD
Cevimeline—Constipation—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000228	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.48e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.46e-05	0.00138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.41e-05	0.00136	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.39e-05	0.00136	CbGpPWpGaD
Cevimeline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.00022	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.31e-05	0.00134	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.29e-05	0.00134	CbGpPWpGaD
Cevimeline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000218	CcSEcCtD
Cevimeline—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000218	CcSEcCtD
Cevimeline—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000212	CcSEcCtD
Cevimeline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000211	CcSEcCtD
Cevimeline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000211	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.01e-05	0.00128	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.95e-05	0.00127	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.93e-05	0.00126	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	5.79e-05	0.00123	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.69e-05	0.00121	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.67e-05	0.00121	CbGpPWpGaD
Cevimeline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.000197	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.64e-05	0.0012	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.62e-05	0.0012	CbGpPWpGaD
Cevimeline—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000191	CcSEcCtD
Cevimeline—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000189	CcSEcCtD
Cevimeline—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.38e-05	0.00115	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.37e-05	0.00114	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	5.3e-05	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	5.28e-05	0.00113	CbGpPWpGaD
Cevimeline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000183	CcSEcCtD
Cevimeline—FMO1—Metabolism—ALB—chronic obstructive pulmonary disease	5.22e-05	0.00111	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.16e-05	0.0011	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.15e-05	0.0011	CbGpPWpGaD
Cevimeline—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000176	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.01e-05	0.00107	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.99e-05	0.00106	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.99e-05	0.00106	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.98e-05	0.00106	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.94e-05	0.00105	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.93e-05	0.00105	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.92e-05	0.00105	CbGpPWpGaD
Cevimeline—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.00017	CcSEcCtD
Cevimeline—Rash—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000168	CcSEcCtD
Cevimeline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000168	CcSEcCtD
Cevimeline—Headache—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000167	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.61e-05	0.000981	CbGpPWpGaD
Cevimeline—Nausea—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000158	CcSEcCtD
Cevimeline—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.54e-05	0.000968	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.00093	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000917	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4e-05	0.000853	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.99e-05	0.00085	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.95e-05	0.000842	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.000839	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.78e-05	0.000806	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.77e-05	0.000804	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.57e-05	0.00076	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.56e-05	0.000758	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.56e-05	0.000758	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.51e-05	0.000748	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.5e-05	0.000746	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.46e-05	0.000738	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.24e-05	0.00069	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.23e-05	0.000688	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.22e-05	0.000686	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.21e-05	0.000683	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.19e-05	0.000679	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.18e-05	0.000677	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-05	0.000674	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.13e-05	0.000666	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.05e-05	0.00065	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.000649	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.04e-05	0.000648	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000647	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.04e-05	0.000647	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.03e-05	0.000645	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.89e-05	0.000617	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.89e-05	0.000615	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000608	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.79e-05	0.000594	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.78e-05	0.000592	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-05	0.00056	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.53e-05	0.000539	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000538	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.33e-05	0.000496	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.26e-05	0.000482	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.23e-05	0.000475	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.000474	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-05	0.000467	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-05	0.000461	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.1e-05	0.000448	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.07e-05	0.000442	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.07e-05	0.00044	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.02e-05	0.000429	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000408	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.000407	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000406	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.89e-05	0.000403	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.87e-05	0.000398	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.72e-05	0.000367	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.72e-05	0.000366	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.71e-05	0.000364	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000363	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.000363	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.000335	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000333	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000332	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.000331	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.00033	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.000319	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.000318	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.39e-05	0.000296	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.39e-05	0.000295	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000279	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-05	0.000277	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000275	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000265	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000263	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.22e-05	0.00026	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000257	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000244	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000243	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000243	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000238	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000232	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000232	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000222	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000221	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000219	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.24e-06	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.21e-06	0.000196	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.79e-06	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.76e-06	0.000187	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.57e-06	0.000183	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.45e-06	0.00018	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.36e-06	0.000178	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.33e-06	0.000178	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.88e-06	0.000168	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.76e-06	0.000165	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.51e-06	0.00016	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.48e-06	0.000159	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.47e-06	0.000159	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.43e-06	0.000158	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.89e-06	0.000147	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.87e-06	0.000146	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.76e-06	0.000144	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.73e-06	0.000143	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.67e-06	0.000121	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.65e-06	0.00012	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.19e-06	0.000111	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.17e-06	0.00011	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.08e-06	0.000108	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.86e-06	0.000103	CbGpPWpGaD
